Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
Rong‐Fu Wang(Houston Methodist), Akio Matsumoto(Kirin (Japan)), Lilia K. Koriazova(Kirin (United States)), Hiroshi Yoshida(Kirin (Japan)), L MADURA(Kirin (United States)), Nan Zhang(North China University of Science and Technology), Aixin Song(Kirin (United States)), Lawrence E. Shapiro(Kirin (United States)), David T. Dennis(Kirin (United States)), Jonathan Levin(University of the Witwatersrand)
Cited by 144
Related Papers
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
|Journal of Neuroinflammation|2019|746
Evaluation of cell-free DNA approaches for multi-cancer early detection
|Cancer Cell|2022|311
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
|Signal Transduction and Targeted Therapy|2023|289
USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors
|Cell Research|2013|174